NASDAQ: HQY

HealthEquity (HQY) Stock Analysis & Forecast

Nov 13 close

$103.46+0.41 (+0.4%)

Gekko Brief

AI summaryNov 9 close

HealthEquity reached a 52-week high of $107.75 this week, extending a run built on strong HSA growth, AI-driven efficiencies and a raised fiscal 2027 outlook, with cybersecurity risks flagged as an ongoing concern. The company also confirmed it will release third-quarter fiscal 2027 results after the close on 1 December 2026, with an investor call to follow. Separately, HQY has been compared against Bausch + Lomb (BLCO) on relative value grounds.

Shares closed at $102.11, down 1.5% on the day, but remain above both the 50-day ($95.64) and 200-day ($89.57) moving averages, with the shorter average above the longer one, pointing to a supportive trend. The GekkoIndex reads 52.3, placing HQY in the Neutral zone. Fair value work puts Gekko Fair Value at $173.68, leaving the stock 41.2% below that level.

The next 20 trading days bring the fiscal third-quarter report on 1 December 2026, falling inside that window and carrying average absolute reactions of 6.5% historically, with 7 beats in the last 8 quarters. No insider, Congress, or unusual options activity appears in their respective 90-day and 30-day windows, though one billionaire holder and one trailblazer holder are noted. Seasonality over this stretch has averaged -9.6% across 5 years, rising in 2 of them, a contrast worth noting against the current uptrend and analyst consensus target of $120.67 from 9 firms, all rated buy.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

HealthEquity price vs fair value

▲$180.37$103.46Nov ’25May ’26Nov ’26
Close $103.46200-day averageGekko Fair Value $180.37

HealthEquity quick facts

Market cap
$8.56B
P/E ratio
37.4
Forward P/E
19
EPS, TTM
$2.77
Revenue, TTM
$1.36B
Profit margin
17.4%
Dividend yield
—
Beta
0.19
Volume
538,683 avg 809,638
1-year return
+2.9%
Typical daily move
±3.3%
Typical 20-day move
±7.4%
50-day average
$96.08
200-day average
$89.96
Next earnings
Dec 1 after close
Shares outstanding
82.72M
52-week range
$72.76$110.26

HealthEquity swing-trade checklist

HealthEquity scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive1 mixed2 headwinds

  • Trendsupportive

    Above 50 and 200-day

    Close $103.46 is above the 50-day ($96.08) and 200-day ($89.96) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    53, Neutral

    Reading 53 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    42.6% below

    Price is 42.6% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings riskheadwind

    Reports in 16 days

    Reports on Dec 1, 2026, 16 days away — inside a typical 20-trading-day hold.

    See earnings
  • Seasonalityheadwind

    −10.3% on average

    From this point in the calendar, the next 20 trading days averaged −10.3% over 5 years, rising in 1 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

HealthEquity stock chart and price history

HealthEquity closed at $103.46 on Nov 13, 2026, +2.9% over the past year, inside a 52-week range of $72.76 to $110.26.

Close50-day average200-day averageVolume
HealthEquity share price, past year, with 50-day and 200-day moving averages and volume$80$90$100$110DecJan 2026FebMarAprMayJunJulAugSepOctNov103.46

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+11.8%
3 months
+1.1%
6 months
+25.9%
1 year
+2.9%
The full HQY chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HQY in Gekko

Follow HealthEquity through every session

Put HQY on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track HQY in GekkoFree for 7 days. No credit card required.

About HealthEquity

HealthEquity offers digital tools that let everyday people and the businesses that employ them keep tabs on healthcare costs and savings. Users can settle medical bills, weigh treatment choices against their prices, view tailored benefit details and clinical records, collect rewards for healthy habits, and build savings using a range of investment options. The company has become closely tied to Health Savings Accounts, which it manages alongside Flexible Spending Accounts and Health Reimbursement Arrangements for its customers nationwide.

On top of these account services, HealthEquity runs a mutual fund investment platform, a digital advisory tool called Advisor, continuation coverage support under COBRA rules, and administration of commuter benefit programs funded with pre-tax dollars. To reach its market, the company relies on its own sales staff as well as ties with benefits brokers and advisors, and it works alongside health plans, benefits administrators, consultants, and record-keepers for retirement plans.

The company traces its founding to 2002 and keeps its headquarters in Draper, Utah. HealthEquity trades on the NASDAQ under the ticker HQY.

Listed
NASDAQ
Sector
Finance
Industry
Investment managers
Website
healthequity.com

HealthEquity GekkoIndex: the smart money zone

HealthEquity’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 53, in the Neutral zone, up 3.5 points over five sessions.

010053Neutral

Up 3.5 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying17+3.0%+2.9%+5.6%+13.2%
Accumulation224+0.1%−0.2%+0.6%+4.6%
Neutral (current zone)411+0.5%+1.1%+1.8%+1.6%
Distribution47−0.5%−0.8%−3.7%−5.7%
Selling3Too few readings yet

Average HQY share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the HQY price, zone by zone.Track HQY in Gekko

Is HealthEquity stock overvalued? Gekko Fair Value

HealthEquity trades 42.6% below Gekko Fair Value of $180.37, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what HealthEquity shares are worth, recalculated every trading day.

$180.37

Gekko Fair Value, Nov 14, 2026

42.6% Undervalued

At the end of Aug 2026 the price was 13.3% below the estimate.

Gekko Fair ValueShare price, month end
$180$103Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open HQY in Gekko

HealthEquity insider and Congress trading

No open-market insider purchases were filed for HealthEquity, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for HQY in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every HQY insider filing, plotted on the chart in Gekko.Open HQY in Gekko

Congress trades last 90 days

No trades in HQY were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for HQY, plotted on the chart in Gekko.Open HQY in Gekko

Buybacks

HealthEquity has been buying back its own shares.

Bought back, quarter ended Jul 31, 2026
$107.7M
As a share of market cap
1.26%
Trailing four quarters
$404.5M

From company filings.

Hedge funds and billionaires quarter ended Jun 30

2of the funds Gekko tracks hold HQY.

0added1opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko

HealthEquity earnings: next date and track record

HealthEquity reports on Dec 1, 2026, after the close (16 days away), and beat the EPS estimate in 7 of its last 8 reports.

7 of 8reports beat the EPS estimate
±6.5%average move across the report
4 of 8reports followed by a gain

Share-price move across each report

−4.8%Dec ’24−16.3%Mar ’25+10.0%Jun ’25+7.0%Sep ’25−3.2%Dec ’25+1.1%Mar ’26+1.7%May ’26−7.7%Aug ’26

Last earnings call, Aug 27, 2026 AI summary

What they said
HealthEquity reported Q2 fiscal 2027 results with accelerated revenue growth and a record adjusted EBITDA margin of 48%. HSA accounts reached a record 10.7 million, up 8% YoY, with total HSA assets growing 14% YoY. New HSAs from sales grew 24% YoY, setting a Q2 record. Client retention remains above 90%, and monthly active app users hit 1.4 million in July, up 62% YoY. Management raised fiscal 2027 guidance on the back of strong execution.
Guidance
Management raised fiscal 2027 guidance following strong Q1 and Q2 execution. Fiscal 2028 guidance will be provided when fiscal 2027 year-end results are reported. An Investor Day is scheduled for April 13, 2027 at company headquarters.
ReportedEPSSurpriseRevenueSurpriseMove
Aug 27, 2026$1.24
est $1.19
+4.2%$350.7M
est $349.2M
+0.4%−7.7%
May 28, 2026$1.07
est $0.94
+13.8%$354.6M
est $352.0M
+0.7%+1.7%
Mar 17, 2026$0.95
est $0.90
+5.8%$334.6M
est $332.3M
+0.7%+1.1%
Dec 3, 2025$1.01
est $0.91
+11.0%$322.2M
est $320.6M
+0.5%−3.2%
Sep 2, 2025$1.08
est $0.91
+18.2%$325.8M
est $320.7M
+1.6%+7.0%
Jun 3, 2025$0.97
est $0.81
+19.3%$330.8M
est $322.3M
+2.7%+10.0%
Mar 18, 2025$0.69
est $0.72
−4.2%$311.8M
est $305.8M
+2.0%−16.3%
Dec 9, 2024$0.78
est $0.72
+8.3%$300.4M
est $290.1M
+3.6%−4.8%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

HealthEquity stock forecast and analyst price targets

Analysts’ average 12-month price target for HealthEquity is $120.67, +16.6% from the last close, from 9 firms rating the stock in the last 90 days.

$120.67consensus 12-month target, +16.6% from the last close
Low $108High $142
Buy9
Hold0
Sell0

Each firm’s latest rating in the last 90 days: 9 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Oct 21BMO CapitalBuy, reiterated$125+20.8%
Oct 16Bank of America SecuritiesBuy, maintained$125+20.8%
Oct 6RBC CapitalBuy, maintained$108+4.4%
Sep 29Wells FargoBuy, reiterated$125+20.8%
Sep 25Wells FargoBuy, maintained$125+20.8%
+1.8%average 20-day move after past Neutral readings
−10.3%average move over the next 20 trading days in the last 5 years
±3.3%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

HealthEquity seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, HealthEquity averaged −10.3% across the last 5 years, rising in 1 of them.

Next 20 trading days, by year

−40.2%2021−4.7%2022−0.9%2023−0.1%2024−5.9%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days−0.6%2 of 5
Next 10 trading days−2.9%2 of 5
Next 15 trading days−6.9%3 of 5
Next 20 trading days−10.3%1 of 5
Next 30 trading days−9.6%1 of 5

For scale, HQY’s typical 20-trading-day move in either direction is about 7.4%.

HealthEquity market cap and key statistics

HealthEquity’s market cap is $8.56B, with a P/E ratio of 37.4 and revenue of $1.36B over the last twelve months.

Valuation

Market cap
$8.56B
P/E ratio
37.4
Forward P/E
19
EPS, TTM
$2.77
Gekko Fair Value
$180.37

Trading

Volume
538,683
Avg volume, 20 days
809,638
52-week high
$110.26
52-week low
$72.76
Shares outstanding
82.72M

Financials

Revenue, TTM
$1.36B
Profit margin
17.4%
Return on equity
11.4%
Quarterly earnings growth, YoY
+14.7%

Risk and income

Beta
0.19
Typical daily move
±3.3%
Typical 20-day move
±7.4%

HealthEquity stock news this week

1 headline about HealthEquity from the past week, newest first, each linking to the publisher.

HealthEquity peers

HealthEquity’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
MSMorgan Stanley−0.7%Neutral4.8% below
BLKBlackRock−0.5%Neutral0.9% above
UBSUBS−0.1%Neutral6.2% below
BXBlackstone+0.2%Neutral5.3% below
BNBrookfield−1.6%Neutral8.7% below
KKRKKR0.0%Neutral7.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Investment managers

HealthEquity stock FAQ

What is HealthEquity’s market cap?

HealthEquity’s market cap is $8.56B at the Nov 13, 2026 close of $103.46, with 82.72M shares outstanding. The shares trade on a P/E ratio of 37.4.

What is the HealthEquity stock forecast?

The consensus analyst 12-month price target for HealthEquity is $120.67, +16.6% from the last close. Of the 9 firms that rated the stock in the last 90 days, 9 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is HealthEquity stock overvalued or undervalued?

On Gekko’s estimate HealthEquity is undervalued: the Nov 13, 2026 close of $103.46 is 42.6% below Gekko Fair Value of $180.37. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does HealthEquity report earnings next?

HealthEquity is expected to report on Dec 1, 2026, after the market closes (16 days away). Analysts expect earnings of $1.15 per share on revenue of $347.2M. HealthEquity beat the earnings estimate in 7 of its last 8 reports, moving 6.5% on average across the report.

What is HealthEquity’s 52-week high and low?

HealthEquity’s 52-week high is $110.26 and its 52-week low is $72.76; it closed at $103.46 on Nov 13, 2026, +2.9% over the past year. Over the last five years the shares peaked at $116.65 on Jun 5, 2025.

Is HealthEquity stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and fair value), 1 as mixed (gekkoindex) and 2 as headwinds (earnings risk and seasonality). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See HealthEquity the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.